# Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)

> **NCT02859623** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 86 (actual)

## Conditions studied

- Blastic Plasmacytoid Dendritic Cell Neoplasm
- Hematological Malignancies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02859623
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-05
- **Final completion:** —
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2016-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02859623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02859623, "Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02859623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*